http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
장원만,이병철,안세영,두호경,안영민,Jang, Won-Man,Lee, Byung-Cheol,Ahn, Se-Young,Doo, Ho-Kyung,Ahn, Young-Min 대한한방내과학회 2007 大韓韓方內科學會誌 Vol.28 No.2
Objective : It has been reported that two-repeats ($IL1RN^{\ast}2$) of interleukin-1 receptor antagonist (IL-1Ra) gene is associated with ischemic stroke, and that Ala allele of the common Pro12Ala polymorphism in $PPAR-{\gamma}2$ isoform is associated with reduced risk for type 2 DM and its complications. The aim of the present study is to assess the association of IL-1Ra and $PPAR-{\gamma}2$ Pro12Ala polymorphism with the presence of ischemic stroke in the case of diabetic and non-diabetic patients. Methods : Genomic DNA was obtained from 373 healthy subjects, 157 DM subjects without ischemic stroke (known DM duration ${\ge}10$ years) and 302 ischemic stroke patients (including with DM). IL-1Ra polymorphism was analysed by polymerase chain reaction (PCR), and $PPAR-{\gamma}2$ polymorphism by restriction fragment length polymorphism after PCR. Results : $IL1RN^{\ast}1/IL1RN^{\ast}2$ genotype was associated with significantly increased risk for DM (OR=2.86, P = 0.0008) and ischemic stroke (OR=2.74, P = 0.0016). Pro/Ala genotype was associated with the reduced risk for DM (OR=0.53, P = 0.0491) and ischemic stroke (OR=0.38, P = 0.0039). They were also associated with the reduced risk for ischemic stroke in the DM patients compared with DM without ischemic stroke (OR=0.25, P = 0.0321). Conclusions : $IL1RN^{\ast}2$ allele could be an accelerating factor, not a predictive marker for ischemic stroke in type 2 DM. The Pro/Ala genotype of $PPAR-{\gamma}2$ Pro12Ala polymorphism may be associated with reduced risk for ischemic stroke with type 2 DM. Therefore it could be a useful predictive marker for ischemic stroke in Korean type 2 DM.
이진신,이병철,장원만,안영민,안세영,두호경,최기림,Lee, Jin-Sin,Lee, Byung-Cheol,Jang, Won-Man,Ahn, Young-Min,Ahn, Se-Young,Doo, Ho-Kyung,Choi, Ki-Lim 대한한방내과학회 2000 大韓韓方內科學會誌 Vol.21 No.4
Vesicoureteral reflux(VUR) is a state that urine regurge from bladder to ureter and kidney because of congenital, structural, functional abnormality of ureterovesical junction and lower urinary tract than bladder. It may be the primary cause of recurrent urinary tract infection(UTI) in chindhood, If urine regurge with UTI, it can cause renal damage, leading to scar formation, hypertension, chronic renal failure, But upper complications can be prevented by early diagnosis and proper treatment of VUR and UTI, so clinician must focus on them in treatment of VUR. We had experienced a case of recurrent UTI with VUR regardless of consistent antibiotics therapy in 7 years old boy, Chief complain was urinary frequency, The symptom of urinary frequency was successfully treated by herb medicine(Gamijihwag-tang), So, we report this case with a brief review of related literatures.
'Chinese Herb Nephropathy'란 용어는 올바른 것인가?
최기림,이진신,장원만,안영민,안세영,두호경,이병철,Choi, Ki-Lim,Lee, Jin-Sin,Jang, Won-Man,Ahn, Young-Min,Ahn, Se-Young,Doo, Ho-Kyung,Lee, Byung-Cheol 대한한방내과학회 2000 大韓韓方內科學會誌 Vol.21 No.4
After Vanherweghem J-L reported the rapidly progressive interstitial renal fibrosis that developed in patients taking the slimming preparation compounded with chinese Herb in Belgium 1993. Chinese Herb Nephropathy(CHN) has become known as a new renal disease, CHN is described as the decrease of urinary renal enzyme, neutral endopeptidase(NEP). N-acetyl-${\beta}$-Dglucosaminidase(NAG). increase of urinary low molecular protein, ${\alpha}$1-microglobulin, ${\beta}$2-microglobulin. clara cell protein(CC16), retinol-binding protein(RBP) in clinical findings, and the proximal tubular atrophy, interstitial fibrosis. urothelial atrophy. glomerular sclerosis in histology, Because CHN was caused by Chinese herb contained in slimming preparation, western medical doctors have thought that all Herb medicine might have caused renal disease and prohibit the taking of any Herb medicine, However. CHN was actually caused by the aristolochic acid contained in some Herb medicines. Aristolochia manshuriensis, Aristolochia fang chi, which is the substitutions of Akebia quinata, Stephania tetrandra has being used in clinical. Aristolochia manshuriensis. Aristolochia fang chi were different with Akebia quinata. Stephania tetrandra in botany, and it have not been classified with medicines in Oriental medicine, That is, the aristolochic acid, not Herb medicines. causes CHN, So, Chinese Herb Nephropathy should be changed to Aristolochic acid Nephropathy.
Collagen Binding Domain (CBD)과 융합된 재조합 Epidermal Growth Factor (EGF)의 과발현 및 가용화의 최적화
강민정(Min Jung Kang),김동균(Dong-Gyun Kim),장원제(Won Je Jang),조화진(Hwa Jin Cho),김장호(Jang-Ho Kim),탁진영(Jin Yeong Tak),양승환(Seung Hwan Yang),김진만(Jin Man Kim) 한국생물공학회 2017 KSBB Journal Vol.32 No.4
Previously, we constructed the recombinant plasmid which containing human epidermal growth factor and collagen binding domain for overproduction of fused biofunctional protein. However, this fusion protein was expressed in Escherichia coli as insoluble protein form in cytoplasm. Therefore, effective denaturation and dialysis process is critical for solubilization and refolding in protein purification process. We attempted several chemicals and buffer conditions for induction, dialysis, and solubilization. Using lactose instead of isopropyl β-D-1-thiogalactopyranoside, expression of target protein was induced. 20 mM tris-HCl buffer for dialysis was suitable for the activity and soluble form of fusion protein. Furthermore, for the solubility of expressed inclusion protein, we conducted with various pH conditions and concentrations of urea and guanidine hydrochloride. The efficient solubility of inclusion body form of fusion protein was showed at alkaline pH condition containing urea.
기계 호흡 중 불안정한 호흡역학을 보인 환자에서 압력조절용적조정양식(Pressure-regulated Volume Control Mode)의 효용
손장원 ( Jang Won Sohn ),고윤석 ( Youn Suck Koh ),임채만 ( Chae Man Lim ),심태선 ( Jong Deog Lee ),이종덕 ( Tae Sun Shim ),이상도 ( Sang Do Lee ),김우성 ( Woo Sung Kim ),김동순 ( Dong Soon Kim ),김원동 ( Won Dong Kim ) 대한결핵 및 호흡기학회 1997 Tuberculosis and Respiratory Diseases Vol.44 No.6
동일한 상시 호흡량의 $N_2-O_2$ 및 Heliox 투여 시 가스교환지표의 비교
손장원,임채만,고윤석,이종덕,이상도,김우성,김동순,김원동,Sohn, Jang-Won,Lim, Chae-Man,Koh, Youn-Suck,Lee, Jong-Deog,Lee, Sang-Do,Kim, Woo-Sung,Kim, Dong-Soon,Kim, Won-Dong 대한결핵및호흡기학회 1998 Tuberculosis and Respiratory Diseases Vol.45 No.1
연구배경: Heliox는 기도 저항이 증가된 환자에서 분시환기량의 증가와 호흡일의 감소로 인해 $PaCO_2$가 감소함이 알려져 있다. 이러한 효과 이외에도 최고 호기 유량비의 증가와 가스 분포의 호전에 의한 사강 호흡률의 감소효과도 있을 것으로 기대된다. 이에 저자등은 공기($N_2-O_2$)호흡 시와 통일한 분시환기량과 호흡일의 조건에서 heliox투여로 $PaCO_2$가 감소하는지 연구하였다. 대상 및 방법: 호흡 부전으로 기계호흡 중인 환자 중 기관지 천식이나 상기도 협착이 있으며 근 이완제 투여로 자신의 호흡일이 없는 8명(남 : 여 =5 : 3, 평균 68세)을 대상으로 하였다. 연구는 각 15분씩 기저 $N_2-O_2$투여, heliox투여 및 washout순으로 진행하였다. Heliox는 Servo 900C기종의 저압입구(low pressure inlet)를 통해 공급하였다. 호흡 역학 지표는 CP-100 monitor(Bicore, USA)로 측정하였고 heliox 투여시 동일한 일호흡량 유지을 위해 $N_2-O_2$에 대한 상대유량 비로 상시 호흡량을 보정하였다. 사강 호흡률용 Bohr의 공식으로 구하였다. 결 과: 일호흡량, 분시환기량, 최고 흡기압 및 최고 흡기 유량 비는 $N_2-O_2$와 heliox투여 군 사이에 차이가 없었다. 최고 호기 유량 비는 heliox투여 군에서 ($0.52{\pm}0.19$L/sec) $N_2-O_2$투여 군($0.44{\pm}0.13$L/sec)보다 높았다 (p=0.024). $PaCO_2$는 heliox투여 군 ($56.1{\pm}14.1$mmHg)이 $N_2-O_2$투여 군 ($60.5{\pm}15.9$mmHg) 보다 낮았고 (p=0.027), 사강 호흡률은 heliox투여군 ($71{\pm}10%$)이 $N_2-O_2$ 투여 군 ($73{\pm}9%$)보다 낮았다. 결 론: 분시환기량과 호흡일이 동일한 조건에서도 heliox투여 시 $N_2-O_2$투여에 비해 $PaCO_2$의 감소가 관찰되며 이는 사강 호흡률의 감소와 관련이 있을 것으로 사료된다. Background: Heliox is known to decrease $PaCO_2$ in patients with increased airway resistance by increasing minute ventilation and reducing work of breathing(WOB). Besides these effect, heliox is expected to decrease functional anatomic dead space owing to improvement of peak expiratory flow rate(PEFR) and enhancement of gas distribution. We investigated whether heliox can decrease $PaCO_2$ even at the same minute ventilation (VE) and WOB with $N_2-O_2$ to speculate the effect of the heliox on the anatomic dead space. Material and Method: The subjects were 8 mechanically ventilated patients with asthma or upper airway obstruction(M : F=5 : 3, $68{\pm}10$years) who were under neuromuscular paralysis. The study was consisted of three 15-minutes phases: basal $N_2-O_2$ heliox and washout Heliox was administered via the low pressure inlet of servo 900C, and respiratory parameters were measured by pulmonary monitor(CP-100 pulmonary monitor, Bicore, Irvine, CA, USA). To obtain the same tidal volume(Vt) in heliox phase, the Vt on monitor was adjusted by the factor of relative flow rate of heliox to $N_2-O_2$. Dead space was calculated by Bohr equation. Results: 1) Vt, VE, peak inspiratory pressure(PIP) and peak inspiratory flow rate(PIFR) were not different between $N_2-O_2$ and heliox. 2) PEFR was higher on heliox($0.52{\pm}0.19$L/sec) than $N_2-O_2$($0.44{\pm}0.13$L/sec)(p=0.024). 3) $PaCO_2$(mmHg) were decreased with heliox($56.1{\pm}14.1$) compared to $N_2-O_2$($60.5{\pm}15.9$)(p=0.027). 4) Dead space ventilation(%) were decreased with heliox($73{\pm}9$ with $N_2-O_2$ and $71{\pm}10$ with heliox)(p=0.026). Conclusion: Heliox decreased $PaCO_2$ even at the same VE and WOB with $N_2-O_2$, and the effect was considered to be related with the reduction of anatomic dead space.